Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

0.6056
-0.0364-5.67%
Post-market: 0.63000.0244+4.03%16:30 EDT
Volume:2.83M
Turnover:1.73M
Market Cap:112.70M
PE:-1.05
High:0.6430
Open:0.6430
Low:0.5949
Close:0.6420
Loading ...
Mar 05, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 11, 2024

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Sep 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities